Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Minding the Money: A Conversation with Douglas White, MD, PhD, Finance Committee Chair

Vanessa Caceres  |  December 18, 2019

Just as financial management can be an important part of a rheumatologist’s practice, managing organizational finances is critical for supporting and sustaining the ACR’s programs. As the ACR treasurer and the new chair of the Committee on Finance, rheumatologist Douglas White, MD, PhD, Gundersen Health System, Onalaska, Wis., will help oversee the ACR’s financial policies, investments and expenses. Dr. White recently shared with The Rheumatologist some information on his background and goals for his work on the Finance Committee.

The Rheumatologist (TR): Why were you interested in becoming chair of the Finance Committee?

Douglas WHite

Dr. Douglas White

Dr. White: My time as a volunteer with the ACR has been incredibly rewarding, both because of the mission and especially because of the people I’ve met along the way. So I’m happy to continue to serve in whatever capacity ACR leaders find helpful. Of course, an assignment like the Finance Committee wouldn’t be possible for a rheumatologist like me, with no formal business training, without Colleen Merkel (VP of operations and finance for the ACR) and her incredible finance team.

TR: What previous work had you done related to this committee or other ACR committees?

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. White: The Committee on Rheumatologic Care and the board of directors have been my main assignments, where I learned the ropes from people including Will Harvey, MD, MSc, Rachel Myslinski, Tim Laing, MD, Angus Worthing, MD, Charles King, MD, Jinoos Yazdany, MD, MPH, Adam Cooper, MS, Elizabeth Perkins, MD, David Daikh, MD, PhD, Kwas Huston, MD, Sean Fahey, MD, Howie Blumstein, MD, Colin Edgerton, MD, Gwen Melton, MD, Ed Herzig, MD, Meredith Strozier, Sandra Mintz, MSN, RN, Lisa Suter, MD, Alex Limanni, MD, Antanya Chung, Jane Kang, MD, MS, and so many more. Many of these connections have come through liaison assignments to the committees on Ethics, Registries and Health Information Technology, and Annual Meeting Planning. I’ve also been a part of the Alternative Payment Model workgroup; the Academic Research, Training and Workforce Taskforce; and strategic planning efforts.

TR: What are the biggest challenges right now for rheumatologists or for the ACR related to finance?

Dr. White: The biggest current challenge for rheumatologists, I think, is adapting to changes in the way they get paid for taking care of patients. As far as the ACR’s finances, I think we need to continue to seek ways to diversify the organization’s revenue streams and increase transparency around how the ACR spends member dues. I suspect the average rheumatologist would be very pleasantly surprised to see the incredible thoughtfulness and care that goes into the design and delivery of ACR programs.

Page: 1 2 | Single Page
Share: 

Filed under:American College of Rheumatology Tagged with:Committee on FinanceDr. Douglas White

Related Articles

    New ACR/ARP Committee Members Are Ready to Work

    January 16, 2020

    Volunteering is a great way to give back and can be truly meaningful. Myriad worthwhile causes exist, so it can be hard to choose among them, but donating time to ACR and ARP committees helps promote rheumatology practice and brings awareness to rheumatic diseases. The College relies on volunteers to help achieve strategic priorities, promote…

    A New President Takes the ACR Helm: Introducing Douglas White, MD, PhD

    November 17, 2022

    In his new role as the 86th president of the ACR, Douglas White, MD, PhD, is excited about the opportunities to serve and energize the organization and members in the coming year.

    Rheumatologists, Physical Therapists Partner to Offer Patients Pain Relief, Improved Quality of Life

    February 16, 2016

    When rheumatoid arthritis (RA) left Stefanie Gluckman fighting chronic pain and relegated to a wheelchair, she turned to Lori Rubenstein Fazzio, DPT, PT, MAppSc, YTRX, of Mosaic Physical Therapy in Los Angeles, for relief. Dr. Rubenstein Fazzio knows what it’s like to suffer from excruciating pain. After sustaining career-threatening injuries in a horseback accident in…

    U.S. Senate Finance Committee Invites Pharma Execs to Testify

    February 5, 2019

    WASHINGTON (Reuters)—A powerful U.S. Senate committee on has invited seven pharmaceutical companies to testify at a hearing later this month examining rising prescription drug prices. Sen. Chuck Grassley (R-IA), chairman of the Senate Finance Committee, and Sen. Ron Wyden (D-Ore.), ranking member of the committee, invited executives from AbbVie Inc., AstraZeneca PLC, Bristol-Myers Squibb Co.,…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences